Third WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials, Changsha, Hunan, China December 12-14, 2018: "The 2018 Changsha Communiqué" The 10-Year Anniversary of The International Consultation on Xenotransplantation

Affiliations

• ¹ Department of Surgery, Westmead Hospital, Centre for Transplant and Renal Research, Westmead Institute for Medical Research, Sydney Medical School, University of Sydney, Westmead, New South Wales, Australia.
• ² Immunology Research Centre, St Vincent's Hospital, Melbourne, Victoria, Australia.
• ³ University Hospitals Geneva, Geneva, Switzerland.
• ⁴ Center for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
• ⁵ Transplantation and Gene Therapy Institute, Third Xiangya Hospital of Central South University, Changsha, China.
• ⁶ Allegheny Health Network - Carnegie Mellon University, Pittsburgh, Pennsylvania.
• ⁷ Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
• ⁸ Division of Nephrology, College of Medicine, Seoul National University, Seoul, South Korea.
• ⁹ Transplant Immunology Unit, Padua University Hospital, Padua, Italy.
• ¹⁰ Université Catholique de Louvain - Health Science Sector - Laboratory of Experimental Surgery and Transplantation, Brussels, Belgium.
• ¹¹ Department of Surgery and Biomedical Engineering, Clinical Islet Program, University of California, Irvine, California.
• ¹² State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
• ¹³ Division of Organ Transplantation, Department of Surgery, Osaka University, Osaka, Japan.
• ¹⁴ Cardiac Xenotransplantation Program, University of Maryland School of Medicine, Baltimore, Maryland.
• ¹⁵ Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South Korea.
• ¹⁶ Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea.
• ¹⁷ Xenotransplantation Research Center, Seoul, South Korea.
• ¹⁸ SchuBiomed Consultancy, Utrecht, The Netherlands.
• ¹⁹ Department of Biological and Biomedical Sciences, School of Health and Life Sciences, Glasgow, Caledonian University, Glasgow, UK.
• ²⁰ Columbia Center for Translational Immunology, Department of Medicine, Columbia University and Columbia University Medical Center, New York, New York.
• ²¹ University of Alabama Birmingham School of Medicine, Birmingham, Alabama.
• ²² Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Division of Medical Biotechnology Section 6/4, Non-vital Tissue Preparations and Xenogeneic Cell-Therapeutics, Langen, Germany.
• ²³ Gene Center, Ludwig Maximilian University of Munich, Munich, Germany.
• ²⁴ World Health Organization, Geneva, Switzerland.
• ²⁵ Cell Transplantation and Gene Therapy Institute, Third Xiangya Hospital of Central South University, Changsha, China.